Monday, November 20, 2017
 
 
Video: Page (1) of 1 - 10/17/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Marino Withdraws 5 pm

By Clip Syndicate
Two days after a "60 Minutes"-Washington Post report questioning his ties to the pharmaceutical industry, PA Congressman Tom Marino abrubtly withdrew his name to become the country's next drug czar.

http://eplayer.clipsyndicate.com/view/12493/7133408 Video: Marino Withdraws 5 pm
Two days after a "60 Minutes"-Washington Post report questioning his ties to the pharmaceutical industry, PA Congressman Tom Marino abrubtly withdrew his name to become the country's next drug czar.
http://chic.clipsyndicate.com/video/playlist/12493/7133408?cpt=8&wpid=2637 Tue, 17 Oct 2017 20:59:16 +0000 Marino Withdraws 5 pm Two days after a "60 Minutes"-Washington Post report questioning his ties to the pharmaceutical industry, PA Congressman Tom Marino abrubtly withdrew his name to become the country's next drug czar. http://chic.clipsyndicate.com/video/playlist/12493/7133408?cpt=8&wpid=2637 WBRE evening. ((candice)) two days after a "60 minutes"-washington post report questioning his ties to the pharmaceutical industry - pennsylvania congressman tom marino abruptly withdrew his name to become the country's next "drug czar". it was just one week ago at a rally here in the commonwealth, when the president was touting marino nomination for the position. eyewitness news reporter morgan parrish joins us in williamsport with more about the announcement. morgan? ((morgan)) candice good evening, republican tom marino's 10th congressional district spans most of north central pennsylvania - and the appointment to become the next drug czar was seen as the president's way of saying thank-you for marino's early support of trump's candidacy. today - it all fell apart. . "he's a good man. i like tom marino.""well i guess it's his prerogative..it's a good thing" "i read the article in the newspaper and i don't have any feelings either way."all this two days after a "60 minutes"/washington post report that 10th district congressman tom marino was a driving force in key legislation to block potential lawsuits against pharmaceutica l companies in connection with the nation's opioid epidemic. marino had no comment yesterday, the president said he would look into it, then early this morning tweeted that marino had withdrawn from consideration as the nation's next national "drug czar". a short while later, the president said...."he didn't want to have even the preception and i think i don't know i love him as a congressman i love the state of pa and i love him as a congressman but i didn't want there to be any preception and he didn't want any preception so he won't be taking the job. " as for what prompted marino's decision?"i have no idea why he did that. that's sort of between him and president trump."whatever that conversation was, lycoming county commissioner rick mirabito, who's a democrat, says there may be fault beyond marino."there were in fact both democrats and republicans who allowed this to happen. this particular individual happens to be going for a position and that's sort of a whole other issue." the real issue, says mirabito is not how marino voted, but what will congress do next. "i think it's easy for us to get caught up and personzaling this with a particular person but the reality is that the big picture here is that the pharmecutical company spent 100 million dollars lobbying congress on this particular issue with the dea." ((morgan)) the congressman has yet to make any public statement about either the initial "60 minutes-washington post" report, or about today's decision.in williamsport, morgan parrish eyewitness news. ((candice)) thanks morgan. meanwhile the president said he expects to formalize his august 10th national emergency declaration on the opioid crises before the week is over - and send it to congress.





Page: 1


 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The U.S. Daily News - Contact Us - Advertise With Us - Privacy Guidelines